Shares of HCP, Inc. (NYSE:HCP) have been given an average rating of “Hold” by the eighteen research firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $26.58.

A number of research analysts recently issued reports on HCP shares. Bank of America boosted their price objective on shares of HCP from $27.50 to $28.00 and gave the company a “buy” rating in a report on Monday. Capital One Financial started coverage on shares of HCP in a report on Tuesday, July 24th. They issued an “equal weight” rating and a $27.50 price target for the company. Morgan Stanley reduced their price target on shares of HCP from $28.00 to $23.50 and set an “equal weight” rating for the company in a report on Thursday, June 14th. Zacks Investment Research cut shares of HCP from a “hold” rating to a “sell” rating in a report on Tuesday, July 31st. Finally, Mizuho reiterated a “buy” rating and issued a $29.00 price target on shares of HCP in a report on Monday, August 13th.

NYSE HCP traded down $0.01 during trading on Friday, reaching $26.34. 46,296 shares of the stock traded hands, compared to its average volume of 1,885,501. The stock has a market cap of $12.27 billion, a P/E ratio of 13.43, a P/E/G ratio of 6.48 and a beta of 0.28. The company has a debt-to-equity ratio of 1.37, a quick ratio of 0.51 and a current ratio of 0.51. HCP has a fifty-two week low of $21.48 and a fifty-two week high of $29.14.

HCP (NYSE:HCP) last issued its quarterly earnings data on Thursday, August 2nd. The real estate investment trust reported $0.19 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.46 by ($0.27). The firm had revenue of $469.60 million for the quarter, compared to analyst estimates of $463.94 million. HCP had a net margin of 3.39% and a return on equity of 1.12%. The firm’s revenue for the quarter was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.48 EPS. analysts predict that HCP will post 1.82 earnings per share for the current fiscal year.

Several institutional investors have recently added to or reduced their stakes in HCP. Security Capital Research & Management Inc. lifted its position in shares of HCP by 20.2% in the second quarter. Security Capital Research & Management Inc. now owns 12,680,529 shares of the real estate investment trust’s stock worth $327,411,000 after purchasing an additional 2,129,250 shares in the last quarter. Northern Trust Corp lifted its position in shares of HCP by 3.9% in the first quarter. Northern Trust Corp now owns 7,885,612 shares of the real estate investment trust’s stock worth $183,182,000 after purchasing an additional 294,020 shares in the last quarter. Brookfield Asset Management Inc. lifted its position in shares of HCP by 32.3% in the first quarter. Brookfield Asset Management Inc. now owns 7,641,262 shares of the real estate investment trust’s stock worth $177,507,000 after purchasing an additional 1,866,537 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of HCP by 1.4% in the second quarter. Dimensional Fund Advisors LP now owns 7,178,265 shares of the real estate investment trust’s stock worth $185,341,000 after purchasing an additional 100,296 shares in the last quarter. Finally, Resolution Capital Ltd lifted its position in shares of HCP by 118.1% in the second quarter. Resolution Capital Ltd now owns 6,481,980 shares of the real estate investment trust’s stock worth $167,365,000 after purchasing an additional 3,509,889 shares in the last quarter. Institutional investors own 88.26% of the company’s stock.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Featured Article: Understanding Relative Strength Index

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.